WELLINGTON MANAGEMENT GROUP LLP - SPARK THERAPEUTICS INC ownership

SPARK THERAPEUTICS INC's ticker is ONCE and the CUSIP is 84652J103. A total of 157 filers reported holding SPARK THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 3.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of SPARK THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$28,653,000
+1.0%
295,454
+6.7%
0.01%0.0%
Q2 2019$28,360,000
-18.8%
276,997
-9.7%
0.01%
-25.0%
Q1 2019$34,915,000
-68.5%
306,604
-89.2%
0.01%
-71.4%
Q4 2018$110,988,000
-60.5%
2,835,671
-45.0%
0.03%
-52.5%
Q3 2018$281,077,000
-4.1%
5,152,648
+45.5%
0.06%
-9.2%
Q2 2018$293,039,000
+16.4%
3,540,829
-6.3%
0.06%
+14.0%
Q1 2018$251,739,000
+57.1%
3,780,420
+21.3%
0.06%
+62.9%
Q4 2017$160,264,000
+105.0%
3,116,749
+255.5%
0.04%
+94.4%
Q3 2017$78,176,000
+60.0%
876,805
+7.2%
0.02%
+50.0%
Q2 2017$48,859,000
+13.3%
817,854
+1.1%
0.01%
+20.0%
Q1 2017$43,140,000
+134.6%
808,782
+119.5%
0.01%
+100.0%
Q4 2016$18,388,000
-40.7%
368,495
-28.6%
0.01%
-37.5%
Q3 2016$30,998,000
+54.3%
516,122
+31.3%
0.01%
+60.0%
Q2 2016$20,095,000
+56.1%
392,994
-9.9%
0.01%
+66.7%
Q1 2016$12,872,000
-32.5%
436,232
+3.6%
0.00%
-40.0%
Q4 2015$19,075,000
+60.2%
421,000
+47.6%
0.01%
+66.7%
Q3 2015$11,905,000
-60.6%
285,280
-43.5%
0.00%
-62.5%
Q2 2015$30,197,000
-21.4%
504,950
-1.4%
0.01%
-20.0%
Q1 2015$38,403,000512,2200.01%
Other shareholders
SPARK THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Twin Securities, Inc. 290,793$28,201,00017.00%
Boxer Capital, LLC 1,650,000$160,017,00011.60%
One68 Global Capital, LLC 48,066$4,661,00010.64%
EcoR1 Capital, LLC 714,789$69,320,0008.75%
Casdin Capital, LLC 863,300$83,722,834,0008.66%
STANSBERRY ASSET MANAGEMENT, LLC 168,629$16,354,0007.23%
HAVENS ADVISORS LLC 81,300$7,884,0007.17%
Chicago Capital Management, LLC 121,000$11,735,0006.12%
GARDNER LEWIS ASSET MANAGEMENT L P 364,397$35,339,0005.29%
Sandell Asset Management Corp. 153,000$14,838,0004.99%
View complete list of SPARK THERAPEUTICS INC shareholders